AKUS vs PRME
Comparison between Akouos Inc (AKUS, Company) and Prime Medicine Inc (PRME, Company).
AKUS vs PRME - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
AKUS
$490M
PRME
$489M
Max Drawdown
Winner
AKUS
90.86%
PRME
94.55%
Sharpe Ratio
AKUS
0.86
Winner
PRME
1.05
5Y Beta
AKUS
N/A
PRME
2.13
Industry
AKUS
N/A
PRME
Biotechnology
P/E Ratio
Winner
AKUS
-5.30
PRME
-2.26
Debt to Equity
AKUS
0.00%
PRME
0.00%
Free Cash Flow Yield
Winner
AKUS
-15.58%
PRME
-32.43%
P/S Ratio
AKUS
N/A
PRME
121.34
P/B Ratio
Winner
AKUS
2.71
PRME
6.38
AKUS vs PRME - Historical Returns
Returns include dividend reinvestment.
1M
Winner
AKUS
+0.00%
PRME
-15.91%
3M
Winner
AKUS
+95.44%
PRME
-25.60%
6M
Winner
AKUS
+327.33%
PRME
-32.32%
1Y
AKUS
+46.37%
Winner
PRME
+90.07%
Max(CAGR)
Winner
AKUS
-18.12%
PRME
-37.48%
AKUS vs PRME - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | AKUS | PRME |
|---|---|---|
| 2026 | N/A | -21.39% |
| 2025 | N/A | +16.05% |
| 2024 | N/A | -66.67% |
| 2023 | +0.00% | -49.49% |
| 2022 | +46.37% | +20.88% |
| 2021 | -56.25% | N/A |
| 2020 | -9.86% | N/A |
AKUS vs PRME Drawdown Comparison
The maximum drawdown for AKUS was -90.86%, occurring on May 25, 2022. This drawdown has not yet recovered.
The maximum drawdown for PRME was -94.55%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The current AKUS drawdown is -50.63%. The current PRME drawdown is -86.86%.
| Rank | AKUS | PRME |
|---|---|---|
| #1 | -90.86% Sep 14, 2020 - May 25, 2022 | -94.55% Nov 1, 2022 - Apr 8, 2025 |
| #2 | -14.22% Jun 30, 2020 - Aug 28, 2020 | -3.55% Oct 21, 2022 - Oct 25, 2022 |
| #3 | -7.97% Sep 2, 2020 - Sep 8, 2020 | N/A |
| #4 | -4.37% Sep 9, 2020 - Sep 14, 2020 | N/A |
| #5 | -0.80% Aug 28, 2020 - Sep 1, 2020 | N/A |
Correlation
Correlation between AKUS and PRME is -0.66 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.
-0.66
-101
Select Stocks to Compare
Popular: AKUS vs SPYPRME vs SPY
More Comparisons
Compare with similar stocks